Disclosure 0001898490-26-000014-3

SEC FORM 4

$113,396.67

Theravance Biopharma, Inc. (TBPH)

Sale of 6,657 shares at $17.0342 per share.

Reporting Person Farnum Rhonda · Officer Title SVP, COMM & MEDICAL AFFAIRS · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001898490-26-000014 · filed 2026-09-17 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Theravance Biopharma, Inc. (TBPH)." Disclosed 2026-09-17. https://desqlong.com/cards/0001898490-26-000014-3 (retrieved 2026-09-26).